In 2013, Spaulonci et al. carried out an RCT to compare metformin and insulin for GDM treatment for women who were unable to maintain glycemic control with diet and exercise and to discover characteristics that indicate the need for supplementary insulin in women who were initially treated only with metformin [54]. The gene discussed is INS; the disease is gestational diabetes.